Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diarylalkylamine REV-ERB antagonists and their use as medicaments

Diarylalkylamine REV-ERB antagonists and their use as medicaments

US Patent 9611245 · Granted Apr 4, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrazole derivatives for the treatment of cystic fibrosis2025
Compounds and compositions for the treatment of cystic fibrosis2025
Pyrazole derivatives as H4 antagonist compounds2025
Compounds and compositions for the treatment of cystic fibrosis2024
Pyrazole derivatives for the treatment of cystic fibrosis2023
Synergistic composition as a promoter of autophagy2022
Compounds and compositions for the treatment of cystic fibrosis2021
Therapeutically active bicyclic-sulphonamides and pharmaceutical compositions2020
Heterocyclic derivatives for the treatment of cystic fibrosis2020
Piperazinyl methanone NAAA inhibitors2020
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioava2019
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioava2019